{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:24:02Z","timestamp":1784733842767,"version":"3.55.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","amjmedsci.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.amjms.2024.05.017","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:09:59Z","timestamp":1716390599000},"page":"415-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["D-dimers in advanced liver cirrhosis: Useful biomarker or not?"],"prefix":"10.1016","volume":"368","author":[{"given":"Lavinia Alice","family":"Balaceanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ion","family":"Dina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2024.05.017_bib0001","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ijlh.13550","article-title":"International Council for standardization in haematology (icsh) laboratory guidance for the verification of haemostasis analyser-reagent test system. Part 2: specialist tests and calibrated assays","volume":"43","author":"Gardiner","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0002","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","article-title":"A Test in Context: D-Dimer","volume":"70","author":"Weitz","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0003","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/jth.14134","article-title":"A re-evaluation of the D-Dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH","volume":"16","author":"Suzuki","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjms.2024.05.017_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjms.2024.05.017_bib0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/OAEM.S238696","article-title":"D-Dimer tests in the emergency department: current insights","volume":"13","author":"Innocenti","year":"2021","journal-title":"Open Access Emerg Med"},{"key":"10.1016\/j.amjms.2024.05.017_bib0006","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ajh.25482","article-title":"The D-Dimer assay","volume":"94","author":"Johnson","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0007","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/s-0040-1718924","article-title":"Fibrinolysis in patients with liver disease","volume":"47","author":"Von Meijenfeldt","year":"2021","journal-title":"Semin Thrombosis Hemost"},{"key":"10.1016\/j.amjms.2024.05.017_bib0008","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2024.05.017_bib0009","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ajcp\/aqw195","article-title":"Disseminated intravascular coagulation","volume":"146","author":"Boral","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.amjms.2024.05.017_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2036.2007.03509.x","article-title":"Review article: coagulation disorders in chronic liver disease","volume":"26","author":"Peck-Radosavljevic","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjms.2024.05.017_bib0011","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.3748\/wjg.v21.i35.10062","article-title":"Coagulopathy in liver disease: lack of an assessment tool","volume":"21","author":"Blasi","year":"2015","journal-title":"Word J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0013","unstructured":"Intagliata N, Shah NL. Hemostatic abnormalities in patients with liver disease. uptodatecom (Accessed 12 July 2022)"},{"key":"10.1016\/j.amjms.2024.05.017_bib0014","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/j.1538-7836.2012.04901.x","article-title":"Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests","volume":"10","author":"Rijken","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjms.2024.05.017_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tmrv.2014.03.002","article-title":"Hemostasis in liver disease: implications of new concepts for perioperative management","volume":"28","author":"Weeder","year":"2014","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.amjms.2024.05.017_bib0016","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease:evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2024.05.017_bib0017","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0018","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.3748\/wjg.v27.i42.7285","article-title":"Hemostasis testing in patients with liver dysfunction: advantages and caveats","volume":"27","author":"Nguyen","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cld.2008.09.008","article-title":"Hyperfibrinolysis in liver disease","volume":"13","author":"Ferro","year":"2009","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.amjms.2024.05.017_bib0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccc.2005.03.002","article-title":"Hemostatic defects in end stage liver disease","volume":"21","author":"Kujovich","year":"2005","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.amjms.2024.05.017_bib0021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11739-009-0345-1","article-title":"New concepts of coagulation and bleeding in liver disease","volume":"5","author":"Northup","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.amjms.2024.05.017_bib0022","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/2050640614560452","article-title":"Managing complications in cirrhotic patients","volume":"3","author":"Peck-Radosavljevic","year":"2015","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.amjms.2024.05.017_bib0023","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/j.1572-0241.1999.02801.x","article-title":"AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state","volume":"94","author":"Joist","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"Suppl1","key":"10.1016\/j.amjms.2024.05.017_bib0024","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/liv.12723","article-title":"The coagulation system in patients with end-stage liver disease","volume":"35","author":"Valla","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.amjms.2024.05.017_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/1076029612461846","article-title":"Venous thromboembolism in cirrhosis","volume":"20","author":"Yang","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.amjms.2024.05.017_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/237351","article-title":"Sonoclot Signature Analysis in Patients with Liver Disease and Its Correlation with Conventional Coagulation Studies","volume":"2013","author":"Saxena","year":"2013","journal-title":"Adv Hematol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0027","first-page":"15296","article-title":"Association between D-Dimer level and portal venous system thrombosis in liver cirrhosis: a retrospective observational study","volume":"8","author":"Dai","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.amjms.2024.05.017_bib0028","first-page":"129","article-title":"Importance of anticoagulant proteins in chronic liver diseases","volume":"16","author":"G\u00fcrsoy","year":"2005","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0029","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhepr.2019.06.002","article-title":"Plasma levels of circulating DNA are associated with outcome, but not with activation of coagulation in decompensated cirrhosis and ACLF","volume":"1","author":"Blasi","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.amjms.2024.05.017_bib0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5455\/medarh.2012.66.372-374","article-title":"Association between high D-Dimer plasma levels and ascites in patients with liver cirrhosis","volume":"66","author":"Saray","year":"2012","journal-title":"Med Arch"},{"key":"10.1016\/j.amjms.2024.05.017_bib0031","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3109\/00365529108998610","article-title":"Increased levels of fibrinolysis reaction products (D-Dimer) in patients with decompensated alcoholic liver cirrhosis","volume":"26","author":"Gram","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0032","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3748\/wjg.14.1549","article-title":"High circulating D-Dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis","volume":"14","author":"Spadaro","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0033","doi-asserted-by":"crossref","DOI":"10.15761\/JTS.1000182","article-title":"Hemostasis, bleeding and thrombosis in liver disease","volume":"3","author":"Flores","year":"2017","journal-title":"J Transl Sci"},{"key":"10.1016\/j.amjms.2024.05.017_bib0034","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/a-1515-9529","article-title":"Intraperitoneal activation of coagulation and fibrinolysis in patients with cirrhosis and ascites","volume":"122","author":"Thaler","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjms.2024.05.017_bib0035","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.30915","article-title":"Mixed fibrinolytic phenotypes in decompensated cirrhosis and acute-on-chronic liver failure with hypofibrinolysis in those with complications and poor survival","volume":"71","author":"Blasi","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0036","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000442877","article-title":"The complex role of anticoagulation in cirrhosis: an updated review of where we are and where we are going","volume":"93","author":"Khoury","year":"2016","journal-title":"Digestion"},{"key":"10.1016\/j.amjms.2024.05.017_bib0037","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.3324\/haematol.2015.139972","article-title":"Endotoxemia as a trigger of thrombosis in cirrhosis","volume":"101","author":"Violi","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.amjms.2024.05.017_bib0038","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0016-5085(95)90342-9","article-title":"Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis","volume":"109","author":"Violi","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0039","first-page":"404","article-title":"Clinical significance of fibrotic, haemostatic and endotoxic changes in patients with liver cirrhosis","volume":"81","author":"Li","year":"2018","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.amjms.2024.05.017_bib0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5114\/ceh.2021.105915","article-title":"Serum and ascitic D-Dimer in cirrhotic patients with spontaneous bacterial peritonitis","volume":"7","author":"El Gohary","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0041","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1111\/j.1572-0241.2000.03299.x","article-title":"Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease","volume":"95","author":"Agarwal","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1969108","article-title":"Significance of heparin-binding protein and D-dimers in the early diagnosis of spontaneous bacterial peritonitis","volume":"2018","author":"Miku\u0142a","year":"2018","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.amjms.2024.05.017_bib0043","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5369001","article-title":"Endothelium, platelets, and coagulation factors as the three vital components for diagnosing bleeding disorders: a simplified perspective with clinical relevance","volume":"2022","author":"Bhattarai","year":"2022","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.amjms.2024.05.017_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1746.2009.06027.x","article-title":"Coagulopathy in liver disease: the whole is greater than the sum of its parts","volume":"25","author":"Hodge","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000103655","article-title":"Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment","volume":"24","author":"Lisman","year":"2007","journal-title":"Dig Surg"},{"key":"10.1016\/j.amjms.2024.05.017_bib0046","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/labmed\/lmw001","article-title":"Widely used types and clinical applications of D-Dimer assay","volume":"47","author":"Riley","year":"2016","journal-title":"Lab Med"},{"key":"10.1016\/j.amjms.2024.05.017_bib0047","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.lab.2005.06.003","article-title":"Evaluation of D-Dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis","volume":"146","author":"Fimognari","year":"2005","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjms.2024.05.017_bib0048","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.dld.2011.10.016","article-title":"Bleeding and thrombosis in cirrhotic patients: what really matters?","volume":"44","author":"Ferro","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.amjms.2024.05.017_bib0049","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.510230613","article-title":"High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia","volume":"23","author":"Ferro","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0050","first-page":"5518","article-title":"Chronic intravascular coagulation in liver cirrhosis predicts a high hemorrhagic risk","volume":"25","author":"Ruberto","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.amjms.2024.05.017_bib0051","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0140-6736(05)76463-1","article-title":"Endotoxemia, hyperfibrinolysis and bleeding in cirrhosis","volume":"353","author":"Basili","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2024.05.017_bib0052","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.28628","article-title":"Coagulation parameters and major bleeding in critically ill patients with cirrhosis","volume":"64","author":"Drolz","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0053","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211054996","article-title":"Age-adjusted D-Dimer in the prediction of pulmonary embolism: systematic review and meta-analysis","volume":"12","author":"Iwuji","year":"2021","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.amjms.2024.05.017_bib0054","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1665-2681(19)31312-2","article-title":"Coagulation abnormalities in the cirrhotic patient","volume":"12","author":"Muci\u00f1o-Bermejo","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/jth.12805","article-title":"Risks of venous thromboembolism in patients with liver cirrhosis: a nationwide cohort study in Taiwan","volume":"13","author":"NG","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjms.2024.05.017_bib0056","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA Clinical Practice Update: coagulation in cirrhosis","volume":"157","author":"O'Leary","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0057","first-page":"e23785","article-title":"Cirrhosis and coagulopathy: mechanisms of hemostasis changes in liver failure and their management","volume":"14","author":"Islam","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.amjms.2024.05.017_bib0058","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral ve- nous thromboembolism","volume":"101","author":"Northup","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0059","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/liv.15183","article-title":"Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications","volume":"42","author":"Zanetto","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.amjms.2024.05.017_bib0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.21037\/cdt-21-98","article-title":"Narrative review of portal vein thrombosis in cirrhosis: pathophysiology, diagnosis, and management from an interventional radiology perspective","volume":"12","author":"Gadani","year":"2022","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.amjms.2024.05.017_bib0061","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4254\/wjh.v6.i2.64","article-title":"Portal vein thrombosis in liver cirrhosis","volume":"6","author":"Kinjo","year":"2014","journal-title":"Word J Hepatol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0062","first-page":"513","article-title":"Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors","volume":"24","author":"Lin","year":"2016","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.amjms.2024.05.017_bib0063","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2021.09.016","article-title":"Diagnostic accuracy of D-Dimer in patients at high-risk for splanchnic vein thrombosis: a systematic review and meta-analysis","volume":"207","author":"Riva","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjms.2024.05.017_bib0064","first-page":"315","article-title":"Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges","volume":"31","author":"Mantaka","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0065","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0066","first-page":"260","article-title":"A single hospital study on portal vein thrombosis in cirrhotic patients - clinical characteristics and risk factors","volume":"139","author":"Chen","year":"2014","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.amjms.2024.05.017_bib0067","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1076029611427900","article-title":"Hemostatic abnormalities in cirrhosis and tumor-related portal vein thrombosis","volume":"18","author":"Alkim","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.amjms.2024.05.017_bib0068","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm-20-4912","article-title":"Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis","volume":"9","author":"Dong","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.amjms.2024.05.017_bib0069","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clinre.2016.03.008","article-title":"Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability","volume":"40","author":"Wosiewicz","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/1319-3767.157567","article-title":"Role of D-Dimer in the development of portal vein thrombosis in liver cirrhosis: a meta-analysis","volume":"21","author":"Dai","year":"2015","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100055","article-title":"Fibrin clot properties and thrombus composition in cirrhosis","volume":"7","author":"Driever","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.amjms.2024.05.017_bib0072","first-page":"e15064","article-title":"D-Dimer: a potential solution to problems of cancer screening, surveillance, and prognosis assessment","volume":"13","author":"Siddiqui","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.amjms.2024.05.017_bib0073","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood.V67.5.1468.1468","article-title":"Analysis of elevated fibrin (OGEN) degradation product levels in patients with liver disease","volume":"67","author":"VanDeWater","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.amjms.2024.05.017_bib0074","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.1840160411","article-title":"Elevated fibrin-related and fibrinogen-related antigens in patients with liver disease","volume":"16","author":"Kruskal","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12876-022-02279-w","article-title":"A comparison of clinical pathological characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China","volume":"22","author":"Chi","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0076","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/CEG.S172663","article-title":"D-Dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis","volume":"11","author":"Malaguarnera","year":"2018","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0077","doi-asserted-by":"crossref","first-page":"e19461","DOI":"10.1097\/MD.0000000000019461","article-title":"Evaluation of plasma D-Dimer for the diagnosis in Chinese patients with hepatocellular carcinoma. A meta-analysis","volume":"99","author":"Fang","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.amjms.2024.05.017_bib0078","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/hep.31201","article-title":"Hemostatic alterations in patients with cirrhosis: from primary hemostasis to fibrinolysis","volume":"71","author":"Zermatten","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.amjms.2024.05.017_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2022.05.012","article-title":"Clinical predictors for thrombus pregression in cirrhotic patients with untreated splanchnic vein thrombosis","volume":"216","author":"McMurry","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjms.2024.05.017_bib0080","article-title":"Biomarkers of liver dysfunction correlate with a prohaemorragic profile in patients with cirrhosis","volume":"2","author":"Zermatten","year":"2020","journal-title":"JHEP Rep"},{"key":"10.1016\/j.amjms.2024.05.017_bib0081","first-page":"6588","article-title":"Predictive value of D-Dimer for portal vein thrombosis after portal hypertension surgery in hepatitis B virus-related cirrhosis","volume":"13","author":"Deng","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0082","doi-asserted-by":"crossref","first-page":"67","DOI":"10.37796\/2211-8039.1186","article-title":"Study of the D-Dimer, C-reactive protein, and autoantibodies markers among HBV infected patients in Babylon province, Iraq","volume":"11","author":"Bayram","year":"2021","journal-title":"BioMedicine"},{"key":"10.1016\/j.amjms.2024.05.017_bib0083","first-page":"11","article-title":"Coagulation profile and its correlation with severity of liver dysfunction and gastrointestinal bleed in alcoholic liver disease patients","volume":"69","author":"Bohania","year":"2021","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.amjms.2024.05.017_bib0084","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41424-018-0002-y","article-title":"Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis","volume":"9","author":"Stine","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0085","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3748\/wjg.v12.i10.1607","article-title":"Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis","volume":"12","author":"Biagini","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0086","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3349\/ymj.1993.34.3.234","article-title":"The fibrinogen degradation products (FGDP) levels in liver disease","volume":"34","author":"Song","year":"1993","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.amjms.2024.05.017_bib0087","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.dld.2016.02.008","article-title":"Hemostatic balance in patients with liver cirrhosis: report of a consensus conference. Under the auspices of the Italian Association for the study of Liver Disease (AISF) and the Italian Society of Internal Medicine (SIMI)","volume":"48","author":"Andriulli","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.amjms.2024.05.017_bib0088","first-page":"129","article-title":"Importance of anticoagulant proteins in chronic liver diseases","volume":"16","author":"G\u00fcrsoy","year":"2005","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0089","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3892\/etm.2016.3930","article-title":"D-Dimer level for predicting the in-hospital mortality in liver cirrhosis: a retrospective study","volume":"13","author":"Li","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.amjms.2024.05.017_bib0090","doi-asserted-by":"crossref","first-page":"e18527","DOI":"10.1097\/MD.0000000000018527","article-title":"Plasma D-Dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis","volume":"98","author":"Zhou","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.amjms.2024.05.017_bib0091","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12876-019-0941-0","article-title":"Elevated D-Dimer is associated with increased 28-day mortality in acute-on- chronic liver failure in China: a retrospective study","volume":"19","author":"Qi","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0092","first-page":"EC24","article-title":"Haemostatic Profile of patients with chronic liver disease- its correlation with severity and outcome","volume":"11","author":"Rai","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.amjms.2024.05.017_bib0093","doi-asserted-by":"crossref","first-page":"e24338","DOI":"10.1002\/jcla.24338","article-title":"Prognostic value of albumin-related ratios in HBV-associated decompensated cirrhosis","volume":"36","author":"Zhang","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.amjms.2024.05.017_bib0094","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4254\/wjh.v14.i4.812","article-title":"Prognostic value of von-Willebrand factor in patients with liver cirrhosis and its relation to other prognostic indicators","volume":"14","author":"Ristovska","year":"2022","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.amjms.2024.05.017_bib0095","article-title":"The association of D-Dimer and spontaneous hemprrhagic ascites with outcomes in cirrhosis: a retrospective study","volume":"65","author":"Fan","year":"2019","journal-title":"Clin Lab"},{"key":"10.1016\/j.amjms.2024.05.017_bib0096","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.3390\/diagnostics12123172","article-title":"Individualized management of coagulopathy in patients with end-stage liver disease","volume":"12","author":"Mahecic","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.amjms.2024.05.017_bib0097","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/life13010132","article-title":"Clinical guideline on perioperative management of patients with advanced chronic liver disease","volume":"13","author":"Canillas","year":"2023","journal-title":"Life"},{"issue":"1 Suppl.1","key":"10.1016\/j.amjms.2024.05.017_bib0098","first-page":"23","article-title":"Current observations in the management of hypo-and hypercoagulability in patients with acute or chronic liver failure","volume":"17","author":"Gish","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.amjms.2024.05.017_bib0099","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","author":"Villa","year":"2022","journal-title":"J Hepatol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924012643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924012643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:31:59Z","timestamp":1729096319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962924012643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0002962924012643"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2024.05.017","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"D-dimers in advanced liver cirrhosis: Useful biomarker or not?","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2024.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}